Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lidocaine for Sedation Reduction in EGD
NCT02620501Unknown
- Sponsor
- Brooke Army Medical Center
- Start
- Jul 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray (2 arms), sponsored by Brooke Army Medical Center. Primary endpoint: Amount of sedation used at 60 minutes. Status: unknown.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT02620501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620501.